| Mrs Murphi E Scarborough, PA-C | |
|
781 Grand Casino Blvd, Shawnee, OK 74804-1005 | |
| (405) 695-6003 | |
| Not Available |
| Full Name | Mrs Murphi E Scarborough |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 5 Years |
| Location | 781 Grand Casino Blvd, Shawnee, Oklahoma |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1588209423 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 3123 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Community Hospital, Llc | Oklahoma city, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Physicians Group, Llc | 8325950603 | 105 |
| Select Physical Therapy Holdings Inc | 9537076401 | 1487 |
News Archive
Pfizer Inc. announced today that it has stopped a Phase 3 clinical trial of Lyrica (pregabalin) in patients with neuropathic pain associated with HIV neuropathy, a form of nerve damage characterized by burning pain usually beginning in the feet. The decision follows review of a planned interim analysis of the study by the trial's external Data Monitoring Committee.
Emory Healthcare is a key player in plans to bring the world's most advanced radiation treatment for cancer patients to Georgia. In furtherance of that role, Emory Healthcare has signed a letter of intent with Advanced Particle Therapy, LLC, of Minden, Nevada, opening the door to a final exploratory phase for development of The Georgia Proton Treatment Center - Georgia's first proton therapy facility.
Stallergenes S.A. announces the results of a phase III clinical trial (VO55.06) conducted in China aimed at assessing the efficacy and safety of sublingual immunotherapy (Staloral(R) mites 300) in adult patients suffering from asthma triggered by house dust mites.
ThromboGenics NV, a biopharmaceutical company focused on developing innovative ophthalmic medicines, today announces that the US Food and Drug Administration (FDA) has notified the Company that its new biologic license application (BLA) for ocriplasmin intravitreal injection will be discussed at the Dermatologic and Ophthalmic Drugs Advisory Committee scheduled for July 26, 2012.
The Seattle Times examines how the Bill & Melinda Gates Foundation's goal to eradicate malaria is shaping aspects of global research.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Murphi E Scarborough, PA-C 2029 Nw 47th St, Oklahoma City, OK 73118-1907 Ph: (405) 623-8505 | Mrs Murphi E Scarborough, PA-C 781 Grand Casino Blvd, Shawnee, OK 74804-1005 Ph: (405) 695-6003 |
News Archive
Pfizer Inc. announced today that it has stopped a Phase 3 clinical trial of Lyrica (pregabalin) in patients with neuropathic pain associated with HIV neuropathy, a form of nerve damage characterized by burning pain usually beginning in the feet. The decision follows review of a planned interim analysis of the study by the trial's external Data Monitoring Committee.
Emory Healthcare is a key player in plans to bring the world's most advanced radiation treatment for cancer patients to Georgia. In furtherance of that role, Emory Healthcare has signed a letter of intent with Advanced Particle Therapy, LLC, of Minden, Nevada, opening the door to a final exploratory phase for development of The Georgia Proton Treatment Center - Georgia's first proton therapy facility.
Stallergenes S.A. announces the results of a phase III clinical trial (VO55.06) conducted in China aimed at assessing the efficacy and safety of sublingual immunotherapy (Staloral(R) mites 300) in adult patients suffering from asthma triggered by house dust mites.
ThromboGenics NV, a biopharmaceutical company focused on developing innovative ophthalmic medicines, today announces that the US Food and Drug Administration (FDA) has notified the Company that its new biologic license application (BLA) for ocriplasmin intravitreal injection will be discussed at the Dermatologic and Ophthalmic Drugs Advisory Committee scheduled for July 26, 2012.
The Seattle Times examines how the Bill & Melinda Gates Foundation's goal to eradicate malaria is shaping aspects of global research.
› Verified 1 days ago
Cary Douglas Nation, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1501 Airport Dr, Shawnee, OK 74804 Phone: 405-273-5801 Fax: 405-878-3814 | |
Laynie Dawn Shebester, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 3315 Kethley Rd, Shawnee, OK 74804 Phone: 405-273-5801 Fax: 405-878-3794 | |
Robert E Peevy, PAC Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 2029 Gordon Cooper Dr, Shawnee, OK 74801 Phone: 405-878-5850 | |
Jared Conatser, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 12 E Macarthur St, Shawnee, OK 74804 Phone: 405-275-1001 | |
Mr. Wade Bittle, P.A.-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 1102 W Macarthur St, Shawnee, OK 74804 Phone: 405-273-2270 | |
Brandi Strayhorn, Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 3700 N Kickapoo Ave, Shawnee, OK 74804 Phone: 405-273-6383 Fax: 580-223-4761 | |
Mrs. Jeanie Kay Johnson Simpson, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 2400 N Harrison St, Shawnee, OK 74804 Phone: 405-395-4441 Fax: 405-438-0540 |